文献速递痛风与晶体性关节病自身炎症与 IgG4 相关病

痛风患者DNA甲基化差异涉及信号网络、转录、固有与适应性免疫及破骨细胞生成基因和通路

Differential DNA Methylation of Networked Signaling, Transcriptional, Innate and Adaptive Immunity, and Osteoclastogenesis Genes and Pathways in Gout.
PubMed 文献 · Arthritis Rheumatol · 2020-03-23

该研究对圣地亚哥队列16例痛风患者和14例匹配健康对照的外周血单个核细胞进行全表观基因组DNA甲基化分析,并在新西兰毛利人独立验证队列(13例痛风、16例对照)中验证。结果显示差异甲基化位点可清晰区分痛风患者与对照,涉及IL23R等基因及B/T细胞受体信号、Th17分化、IL-17信号、NF-κB、mTOR、自噬和破骨细胞分化等通路。

要点

  • 痛风患者外周血单个核细胞存在差异DNA甲基化模式,可区分患者与对照。
  • 差异甲基化涉及IL23R及B/T细胞受体信号、Th17分化、IL-17信号等免疫通路。
  • 破骨细胞分化是两队列重叠的最强差异甲基化通路,NF-κB活化限制性转录因子MEF2C和NFATC2参与。

核心结论

  • 痛风患者存在涉及网络化信号、转录、固有与适应性免疫及破骨细胞生成基因和通路的差异DNA甲基化,可能作为痛风管理的新治疗靶点。

研究设计与样本

  • 研究纳入圣地亚哥队列16例痛风患者和14例 individually matched 健康对照,采集外周血单个核细胞进行全表观基因组甲基化分析。
  • 使用R语言ChAMP包处理甲基化数据,并利用ENCODE数据和Taiji软件分析转录因子-基因网络。
  • 独立验证队列为新西兰毛利人全血DNA样本,包括13例痛风患者和16例无痛风对照。

主要发现

  • 层次聚类和主成分分析显示差异甲基化位点清晰区分痛风患者与对照。
  • IL23R被鉴定为多个差异甲基化痛风风险基因之一,该基因介导肉芽肿形成和细胞侵袭。
  • 全表观基因组分析揭示B和T细胞受体信号、Th17细胞分化和白细胞介素-17信号、长寿调控、昼夜节律同步及AMP活化蛋白激酶信号等通路存在差异甲基化富集。
  • 上述通路通过胰岛素样生长因子1受体、磷脂酰肌醇3-激酶/Akt、NF-κB、雷帕霉素机制靶信号和自噬影响炎症。
  • 两个痛风队列在70个低甲基化序列富集转录因子中重叠37个(52.9%),在转录因子鉴定的38个富集KEGG通路中重叠30个(78.9%)。

临床怎么用

  • 差异DNA甲基化模式及IL23R、MEF2C、NFATC2等基因和破骨细胞分化通路可能为痛风 flares、痛风石、慢性滑膜炎和骨侵蚀提供新的治疗靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: In gout, autoinflammatory responses to urate crystals promote acute arthritis flares, but the pathogeneses of tophi, chronic synovitis, and erosion are less well understood. Defining the pathways of epigenomic immunity training can reveal novel pathogenetic factors and biomarkers. The present study was undertaken to seminally probe differential DNA methylation patterns utilizing epigenome-wide analyses in patients with gout. METHODS: Peripheral blood mononuclear cells (PBMCs) were obtained from a San Diego cohort of patients with gout (n = 16) and individually matched healthy controls (n = 14). PBMC methylome data were processed with ChAMP package in R. ENCODE data and Taiji data analysis software were used to analyze transcription factor (TF)-gene networks. As an independent validation cohort, whole blood DNA samples from New Zealand Māori subjects (n = 13 patients with gout, n = 16 control subjects without gout) were analyzed. RESULTS: Differentially methylated loci clearly separated gout patients from controls, as determined by hierarchical clustering and principal components analyses. IL23R, which mediates granuloma formation and cell invasion, was identified as one of the multiple differentially methylated gout risk genes. Epigenome-wide analyses revealed differential methylome pathway enrichment for B and T cell receptor signaling, Th17 cell differentiation and interleukin-17 signaling, convergent longevity regulation, circadian entrainment, and AMP-activated protein kinase signaling, which are pathways that impact inflammation via insulin-like growth factor 1 receptor, phosphatidylinositol 3-kinase/Akt, NF-κB, mechanistic target of rapamycin signaling, and autophagy. The gout cohorts overlapped for 37 (52.9%) of the 70 TFs with hypomethylated sequence enrichment and for 30 (78.9%) of the 38 enriched KEGG pathways identified via TFs. Evidence of shared differentially methylated gout TF-gene networks, including the NF-κB activation-limiting TFs MEF2C and NFATC2, pointed to osteoclast differentiation as the most strongly weighted differentially methylated pathway that overlapped in both gout cohorts. CONCLUSION: These findings of differential DNA methylation of networked signaling, transcriptional, innate and adaptive immunity, and osteoclastogenesis genes and pathways suggest that they could serve as novel therapeutic targets in the management of flares, tophi, chronic synovitis, and bone erosion in patients with gout.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Wang Z, Zhao Y, Phipps-Green A, et al. Differential DNA Methylation of Networked Signaling, Transcriptional, Innate and Adaptive Immunity, and Osteoclastogenesis Genes and Pathways in Gout. Arthritis Rheumatol. 2020. PMID: 31738005. doi:10.1002/art.41173

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。